A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
NCT06101082
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
BIOLOGICAL:
Intravenous infusion anti-HER2-CAR-T cell
Sponsor
China Medical University, China
Collaborators
[object Object]